FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994302005> ?p ?o ?g. }

• W2994302005 endingPage "29" @default.
• W2994302005 startingPage "23" @default.
• W2994302005 abstract "Objectives: To evaluate the efficacy and safety of adapalene 0.1% benzoyl peroxide 2.5% gel in women aged 25 years or older via subgroup analysis of existing Phase 2 and 3 study data. Methods: Meta-analysis of pooled data from three multicenter, randomized, double-blind, vehicle-controlled, parallel-group, clinical trials compared results of treatment with either adapalene 0.1% benzoyl peroxide 2.5% gel or vehicle gel in adult females and teen-aged females. Efficacy assessments included investigator's global assessment and median percent change in acne lesions. Safety assessments included skin tolerability and adverse events. Results: Two hundred fifty-four adult females and 488 teen-aged females were included in the analyses, and baseline characteristics were comparable between subjects receiving adapalene 0.1% benzoyl peroxide 2.5% or vehicle. Both adult females and teen-aged females in the adapalene 0.1% benzoyl peroxide 2.5% arm were significantly more often rated clear/almost clear compared with those in the vehicle arm at Weeks 8 (P=0.016) and 12 (P<0.001); at endpoint, success was achieved in 39.2 percent with adapalene 0.1% benzoyl peroxide 2.5% and 18.5 percent with vehicle. Comparison of the amount of difference between active and vehicle reductions in investigator's global assessment showed that efficacy was similar for adult females versus teen-aged females (20.7% vs. 19.9%, respectively). Adapalene 0.1% benzoyl peroxide 2.5% had a rapid onset of action, with statistically significant reductions in all acne lesion types versus vehicle observed by Week 1. Adapalene 0.1% benzoyl peroxide 2.5% was safe and well-tolerated by adult females with a tolerability profile consistent with that seen in teen-aged females. Conclusions: The once-daily fixed-dose combination product adapalene 0.1% benzoyl peroxide 2.5% is an efficacious, safe, and well-tolerated treatment for adult female acne, with a profile similar to that in teen-aged females." @default.
• W2994302005 created "2019-12-13" @default.
• W2994302005 creator A5002644565 @default.
• W2994302005 creator A5047077364 @default.
• W2994302005 creator A5048521405 @default.
• W2994302005 creator A5062068107 @default.
• W2994302005 creator A5091365892 @default.
• W2994302005 date "2016-07-01" @default.
• W2994302005 modified "2023-10-01" @default.
• W2994302005 title "Adapalene-benzoyl Peroxide Gel is Efficacious and Safe in Adult Female Acne, with a Profile Comparable to that Seen in Teen-aged Females." @default.
• W2994302005 cites W115872829 @default.
• W2994302005 cites W124106590 @default.
• W2994302005 cites W1608072758 @default.
• W2994302005 cites W1683232213 @default.
• W2994302005 cites W174187323 @default.
• W2994302005 cites W1965659086 @default.
• W2994302005 cites W1975750320 @default.
• W2994302005 cites W1983342608 @default.
• W2994302005 cites W1998934355 @default.
• W2994302005 cites W2025416078 @default.
• W2994302005 cites W2032851482 @default.
• W2994302005 cites W2058499720 @default.
• W2994302005 cites W2065245096 @default.
• W2994302005 cites W2105610837 @default.
• W2994302005 cites W2141218004 @default.
• W2994302005 cites W2141973975 @default.
• W2994302005 cites W2144083903 @default.
• W2994302005 cites W2157086784 @default.
• W2994302005 cites W2170428123 @default.
• W2994302005 cites W2404644884 @default.
• W2994302005 cites W2406953560 @default.
• W2994302005 cites W2415138458 @default.
• W2994302005 cites W28246644 @default.
• W2994302005 cites W4300019986 @default.
• W2994302005 cites W155877267 @default.
• W2994302005 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5023000" @default.
• W2994302005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28331557" @default.
• W2994302005 hasPublicationYear "2016" @default.
• W2994302005 type Work @default.
• W2994302005 sameAs 2994302005 @default.
• W2994302005 citedByCount "4" @default.
• W2994302005 countsByYear W29943020052017 @default.
• W2994302005 countsByYear W29943020052019 @default.
• W2994302005 countsByYear W29943020052020 @default.
• W2994302005 crossrefType "journal-article" @default.
• W2994302005 hasAuthorship W2994302005A5002644565 @default.
• W2994302005 hasAuthorship W2994302005A5047077364 @default.
• W2994302005 hasAuthorship W2994302005A5048521405 @default.
• W2994302005 hasAuthorship W2994302005A5062068107 @default.
• W2994302005 hasAuthorship W2994302005A5091365892 @default.
• W2994302005 hasConcept C126322002 @default.
• W2994302005 hasConcept C16005928 @default.
• W2994302005 hasConcept C168563851 @default.
• W2994302005 hasConcept C178790620 @default.
• W2994302005 hasConcept C185592680 @default.
• W2994302005 hasConcept C197934379 @default.
• W2994302005 hasConcept C203092338 @default.
• W2994302005 hasConcept C2777140388 @default.
• W2994302005 hasConcept C2777673923 @default.
• W2994302005 hasConcept C2778375690 @default.
• W2994302005 hasConcept C2778885487 @default.
• W2994302005 hasConcept C44228677 @default.
• W2994302005 hasConcept C46821324 @default.
• W2994302005 hasConcept C521977710 @default.
• W2994302005 hasConcept C535046627 @default.
• W2994302005 hasConcept C71924100 @default.
• W2994302005 hasConceptScore W2994302005C126322002 @default.
• W2994302005 hasConceptScore W2994302005C16005928 @default.
• W2994302005 hasConceptScore W2994302005C168563851 @default.
• W2994302005 hasConceptScore W2994302005C178790620 @default.
• W2994302005 hasConceptScore W2994302005C185592680 @default.
• W2994302005 hasConceptScore W2994302005C197934379 @default.
• W2994302005 hasConceptScore W2994302005C203092338 @default.
• W2994302005 hasConceptScore W2994302005C2777140388 @default.
• W2994302005 hasConceptScore W2994302005C2777673923 @default.
• W2994302005 hasConceptScore W2994302005C2778375690 @default.
• W2994302005 hasConceptScore W2994302005C2778885487 @default.
• W2994302005 hasConceptScore W2994302005C44228677 @default.
• W2994302005 hasConceptScore W2994302005C46821324 @default.
• W2994302005 hasConceptScore W2994302005C521977710 @default.
• W2994302005 hasConceptScore W2994302005C535046627 @default.
• W2994302005 hasConceptScore W2994302005C71924100 @default.
• W2994302005 hasIssue "7" @default.
• W2994302005 hasLocation W29943020051 @default.
• W2994302005 hasOpenAccess W2994302005 @default.
• W2994302005 hasPrimaryLocation W29943020051 @default.
• W2994302005 hasRelatedWork W2103367276 @default.
• W2994302005 hasRelatedWork W2138211925 @default.
• W2994302005 hasRelatedWork W2239502113 @default.
• W2994302005 hasRelatedWork W2315795079 @default.
• W2994302005 hasRelatedWork W2994302005 @default.
• W2994302005 hasRelatedWork W3132268980 @default.
• W2994302005 hasRelatedWork W4250691982 @default.
• W2994302005 hasRelatedWork W4254332142 @default.
• W2994302005 hasRelatedWork W49852758 @default.
• W2994302005 hasRelatedWork W55905745 @default.
• W2994302005 hasVolume "9" @default.
• W2994302005 isParatext "false" @default.

• next